Attributes | Values |
---|
rdf:type
| |
Description
| - A series of mono- and binuclear 4-arylazo-3,5-diamino-pyrazoles which are useful for inhibition of cyclin-dependent kinases (preferably CDK 9). Hence they can be used as antimitotic-, pro-apoptotic and antiinflammatory drugs, in particular, in chemotherapy of cancer and asthma, therapy of psoriasis and parasitoses as those caused by fungi or protits, treatment of Alzheimer´s disease or as antineurodegenerative drugs, or to suppress immunostimulation. These compounds are useful in a variety of utilities, including as intermediates in the preparation of flame-retardants, diagnostic reagents and therapeutics, including antivirals and immunosuppressors.
- A series of mono- and binuclear 4-arylazo-3,5-diamino-pyrazoles which are useful for inhibition of cyclin-dependent kinases (preferably CDK 9). Hence they can be used as antimitotic-, pro-apoptotic and antiinflammatory drugs, in particular, in chemotherapy of cancer and asthma, therapy of psoriasis and parasitoses as those caused by fungi or protits, treatment of Alzheimer´s disease or as antineurodegenerative drugs, or to suppress immunostimulation. These compounds are useful in a variety of utilities, including as intermediates in the preparation of flame-retardants, diagnostic reagents and therapeutics, including antivirals and immunosuppressors. (en)
|
Title
| - 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
- 4-arylazo-3,5-diamino-pyrazole compounds and use thereof (en)
|
skos:prefLabel
| - 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
- 4-arylazo-3,5-diamino-pyrazole compounds and use thereof (en)
|
skos:notation
| - RIV/61989592:15310/09:00010701!RIV10-MSM-15310___
|
http://linked.open...tracePatentuVzoru
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...cisloPatentuVzoru
| |
http://linked.open...eleniPatentuVzoru
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15310/09:00010701
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - 4-arylazo-3; 5-diamino-pyrazole; cyclin-dependent kinase inhibitor; antimitotic drug; antiinflammatory drug; chemotherapy (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open.../licencniPoplatek
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...atelePatentuVzoru
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...iv/tvurceVysledku
| - Kryštof, Vladimír
- Strnad, Miroslav
- Cankař, Petr
- Lenobel, René
- Fryšová, Iveta
- Slouka, Jan
- Fisher, Peter
|
http://linked.open...mniOchranaPatentu
| |
http://linked.open...avai/riv/vlastnik
| |
http://linked.open...itiJinymSubjektem
| |
http://linked.open...uzitiPatentuVzoru
| |
http://linked.open...n/vavai/riv/zamer
| |
http://linked.open...stnikPatentuVzoru
| - Univerzita Palackého v Olomouci, Ústav Experimentální Botaniky AV ČR
|
http://localhost/t...ganizacniJednotka
| |